Abstract
The search for regulators of angiogenesis has led to the identification of a number of genes that, when tested in vitro or in vivo (in animal models), help to elucidate the complex phenomenon of vascular formation during development and pathologic conditions. Many new growth factors and receptors and other molecules previously thought to be specific for other systems (e.g., the nervous system) have now been found to play a role in angiogenesis and are currently under analysis. One such example is neuropilin-1, which is expressed predominantly in developing neurons (for a review see Fujisawa and Kitsukawa, 1998). Neuropilin-1 null mutants die during embryonic development due to disorganization of nerve pathways (Kitsukawa et al, 1997) as well as several vascular defects (Kawasaki et al, 1999).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Achen, M. G., Gad, J. M., Stacker, S. A., and Wilks, A. F. 1997. Placenta growth factor and vascular endothelial growth factor are co-expressed during early embryonic development. Growth Factors 15:69–80.
Athanassiades, A., and Lala, P. K. 1998. Role of placenta growth factor (PIGF) in human
extravillous trophoblast proliferation, migration and invasiveness. Placenta 19:465–473.
Barillari, G., Albonici, L., Franzese, O., Modesti, A., Liberati, F., Barillari, P., Ensoli, B.
Manzari, V., and Santeusanio, G. 1998. The basic residues of placenta growth factor
type 2 retrieve sequestered angiogenic factors into a soluble form. Am. J. Pathol.
:1161–1166.
Barleon, B., Sozzani, S., Zhou, F., Weich, H. A., Mantovani, A., and Marmé, D. 1996. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87:3336–3343.
Bussolino, F., Mantovani, A., and Persico, G. 1997. Molecular mechanisms of blood vessel formation. Trends Biochem. Sci. 22:251–256.
Cao, Y., Chen, H., Zhou, L., Chiang, M.-K. Anand-Apte, B., Weatherbee, J. A., Wang, Y., Fang, F., Flanagan, J. G., and Lik-Shing-Tsang, M. 1996a. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR. J. Biol. Chem. 271:3154–3162.
Cao, Y., Linden, P., Shima, D., Brone, F., and Folkman, J. 1996b. In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor. J. Clin. Invest. 98:2507–2511.
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau, W., and Nagy, A. 1996. Role of tissue factor in embryonic blood vessel development. Nature 383:73–75.
Carmeliet, P., Vincenti, V., Moons, L., Luttun, A., Devy, L., Scholz, D., Brusselmans, K., Bono, F., Dipalma, T., Stalmans, I., Fukao, H., Dewerchin, M., Noel, M., Lutgens, E., Barra, A., Blacher, S., Laux, V., Detmar, M., Herbert, J.-M., Foidart, J.-M., Schaper, W.,Collen, D., Persico, M. G. 2000. Placental growth factor (PLGF): a specific stimulator of VEGF in pathological angiogenesis and arteriogenesis. Submitted.
Clark, D. E., Smith, S. K., Licence, D., Evans, A. L., and Charnock-Jones, D. S. 1998. Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation. J. Endocrinol. 159:459–467.
Clauss, M., Weich, H. A., Breier, G., Knies, U., Röckl, W., Waltenberger, J., and Risau, W. 1996. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. J. Biol. Chem. 271:17629–17634.
Conn, G., Bayne, M. L., Soderman, D. D., Kwok, P. W., Sullivan, K. A., Palisi, T. M., Hope, D. A., and Thomas, K. A. 1990. Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc. NatL Acad. Sci. USA 87:2628–2632.
Cunningham, S. A., Tran, T. M., Arrate, M. P., and Brock, T. A. 1999. Characterization of vascular endothelial cell growth factor interactions with the kinase insert domain-containing receptor tyrosine kinase. J. BioL Chem. 274:18421–18427.
Davis-Smyth, T., Chen, H., Park, J., Presta, L. G., and Ferrara, N. 1996. The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade. EMBO J. 15:4919–41927.
Desai, J., Holt-Shore, V., Torry, R. J., Caudle, M. R., and Torry, D. S. 1999. Signal transduction of biological function of placenta growth factor in primary human trophoblast. BioL Reprod. 60:887–892.
DiPalma, T., Tucci, M., Russo, G., Maglione, D., Lago, C. T., Romano, A., Saccone, S., DellaValle, G., De Gregorio, L., Dragani, T. A., Viglietto, G., and Persico, M. G. 1996. The placenta growth factor gene of the mouse. Mamm. Genome 7:6–12.
DiSalvo, J., Bayne, M. L., Conn, G., Kwock, P. W., Trivedi, P. G., Soderman, D. D., Palisi, T. M., Sullivan, K. A., and Thomas, K. A. 1995. Purification and characterization of a naturally occurring vascular endothelial growth factor-placenta growth factor. J. BioL Chem. 270:7717–7723.
Donnini, S., Machein, M. R., Plate, K. H., and Weich, H. A. 1999. Expression and localization of placenta growth factor and P1GF receptors in human meningiomas. J. Pathol. 189:66–71.
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O’Shea, K. S., Powell-Braxton, L., Hillan, K. J., and Moore, M. W. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439–442.
Ferrara, N., and Henzel, W. J. 1989. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161:851–858.
Fong, G. H., Rossant, J., Gertsenstein, M., Breitman, M. L. 1995. Role of the Flt-1 recep-
tor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66–70. Fujisawa, H., and Kitsukawa, T. 1998. Receptors for collapsin/semaphorins. Curr. Opin.NeurobioL 8:587–592.
Gospodarowicz, D., Abraham, J. A., and Schilling, J. 1989. Isolation and characterization of a vascular endothelial mitogen produced by pituitary-derived folliculo stellate cells. Proc. Natl. Acad. Sci. USA 86:7311–7315.
Guillemin, K., and Krasnow, M. A. 1997. The hypoxic response: Huffing and HIFing. Cell 89:9–12.
Hatva, E., Bohling, T., Jaaskelainen, J., Persico, M. G., Haltia, M., and Alitalo, K. 1996. Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas. Am. J. Pathol. 148:763–775.
Hauser, S., and Weich, H. A. 1993. A heparin-binding form of placenta growth factor (P1GF-2) is expressed in human umbilical vein endothelial cells and placenta. Growth Factors 9:259–268.
Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., and Alitalo, K. 1996. A novel vascular endothelial growth factor, VEGFC, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15:290–298.
Kawasaki, T., Kitsukawa, T., Bekku, Y., Matsuda, Y., Sanbo, M., Yagi, T., and Fujisawa, H. 1999. A requirement for neuropilin-1 in embryonic vessel formation. Development 126:4895–4902.
Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J., and Connolly, D. T. 1989. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246:1309–1312.
Khaliq, A., Dunk, C., Jiang, J., Shams, M., Li, X. F., Acevedo, C., Weich, H., Whittle, M., and Ahmed, A. 1999. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for “placental hyperoxia” in intrauterine growth restriction. Lab. Invest. 79:151–170.
Khaliq, A., Foreman, D., Ahmed, A., Weich, H., Gregor, Z., McLeod, D., and Boulton, M. 1998. Increased expression of placenta growth factor in proliferative diabetic retinopathy. Lab. Invest. 78:109–116.
Khaliq, A., Li, X. F., Shams, M., Sisi, P., Acevedo, C. A., Whittle, M. J., Weich, H. A., and Asmed, A. 1996. Localization of placenta growth factor (P1GF) in human term placenta. Growth Factors 13:243–250.
Kitsukawa, T., Shimiizu, M., Sanbo, M., Hirata, T., Taniguchi, M., Bekku, Y., Yagi, T., and Fujisawa, H. 1997. Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice. Neuron 19:995–1005.
Landgren, E., Schiller, P., Cao, Y., and Claesson-Welsh, L. 1998. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1. Oncogene 16:359–367.
Levy, A. P., Tamargo, R., Brem, H., and Nathans, D. 1989. An endothelial cell growth factor from the mouse neuroblastoma cell line NB 41. Growth Factors 2:9–19.
Maglione, D., Guerriero, V., Rambaldi, M., Russo, G., Persico, M. G. 1993b. Translation of the placenta growth factor mRNA is severely affected by a small open reading frame localized in the 5’ untranslated region. Growth Factors 8:141–152.
Maglione, D., Guerriero, V., Viglietto, G., Ferraro, M. G., Aprelikova, O., Alitalo, K., Del Vecchio, S., Lei, K. J., Chou, J. Y., and Persice, M. G. 1993a. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (P1GF), are transcribed from a single gene of chromosome 14. Oncogene 8:925–931.
Maglione, D., Guerriero, V., Viglietto, G., Delli-Bovi, P., and Persico, M. G. 1991. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc. Natl. Acad. Sci. USA 88:9267–9271.
Migdal, M., Huppertz, B., Tessler, S., Comforti A., Shibuya, M., Reich, R., Baumann, H., and Neufeld, G. 1998. Neuropilin-1 is a placenta growth factor-2 receptor. J. Biol. Chem. 273:22272–22278.
Nomura, M., Yamagishi, S., Harada, S., Yamashima, T., Yamashita, J., and Yamamoto, H. 1998. Placenta growth factor (P1GF) mRNA expression in brain tumors. J. Neurooncol. 40:123–130.
Olofsson, B., Pajusola, K., von Euler, G., Chilov, D., Alitalo, K., and Eriksson, U. 1996. Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform. J. Biol. Chem. 271:19310–19317.
Orlandini, M., Marconcini, L., Ferruzzi, R., and Oliviero, S. 1996. Identification of a cfos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family.Proc. Natl. Acad. Sci. USA93:11675–11680.
Park, J. E., Chen, H. H., Winer, J., Houck, K. A., and Ferrara, N. 1994. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity,in vitroandin vivo,and high affinity binding to Flt-1 but not to VEGFR-2.J. Biol. Chem. 269:2564625654.
Persico, M. G., Vincenti, V., and DiPalma, T. 1999. Structure, expression and receptor-binding properties of placenta growth factor (P1GF). Curr. Top. Microbiol. Immunol. 237:31–40.
Ratajczak, M. Z., Ratajczak, J., Machalinski, B., Majka, M., Marlicz, W., Carter, A., Pietrzkowski, Z., and Gewirtz, A. M. 1998. Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (P1GF) in regulating human haemopoietic cell growth.Br. J. Haematol. 103:969–979.
Sato, K., Yamazaki, K., Shizume, K., Kanaji, Y., Obara, T., Ohsumi, K., Demura, H., Yamaguchi, S., and Shibuya, M. 1995. Stimulation by thyroid-stimulating hormone and Graves’ immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo.J. Clin. Invest.96:1295–1302.
Sawano, A., Takahashi, T., Yamaguchi, S., Aonuma, M., and Shibuya, M. 1996. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is releated to vascular endothelial growth factor.Cell Growth Differ.7:213–221.
Shalaby, F. Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L., and Schuh, A. C. 1995. Failure of blood-island formation and vasculogenesis in Flk-1deficient mice.Nature 376:62–66.
Shibuya, M., Ito, N., and Claesson-Welsh, L. 1999. Structure and function of vascular endothelial growth factor receptor-1 and -2.Curr. Top. Microbiol. Immunol. 237:5984.
Shore, V. H., Wang, T. H., Wang, C. L., Torry, R. J., Caudle, M. T., and Torry, D. S. 1997. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast.Placenta18:657–665.
Simpson, D. A., Murphy, G. M., Bhaduri, T., Gardiner, T. A., Archer, D. B., and Stitt, A. W. 1999. Expression of the VEGF gene family during retinal vaso-obliteration and hypoxia. Biochem. Biophys. Res. Commun. 262:333–340.
Sowter, H. M., Corps, A. N., Evans, A. L., Clark, D. E., Charnock-Jones, D. S., and Smith, S. K. 1997. Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors.Lab Investigation77:607–614.
Taipale, J., Makinen, T., Arighi, E., Kukk, E., Karkkainen, M., and Alitalo, K. 1999. Vascular endothelial growth factor receptor-3. Curr. Top. Microbiol. Immunol. 237:85–96.
Takahashi, A., Sasaki, H., Kim, S. J., Tobisu, K., Kakizoe, T., Tsukamoto, T., Kumamoto, Y., Sugimura, T., and Terada, M. 1994. Markedly increased amount of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res. 54:4233–4237.
Terman, B. I., Khandke, L., Dougher-Vermazan, M., Maglione, D., Lassam, N. J., Gospodarowicz, D., Persico, M. G., Bohlen, P., and Eisinger, M. 1994. VEGF receptor subtypes KDR and FLT1 show different sensitivities to heparin and placenta growth factor. Growth Factors 11:187–195.
Torry, D. S., Wang, H. S., Wang, T. H., Caudle, M. R., and Torry, R. J. 1998. Preeclampsia is associated with reduced serum levels of placenta growth factor. Am. J. Obstet. Gynecol. 179:1539–1544.
Viglietto, G., Maglione, D., Rambaldi, M., Cerutti, J., Romano, A., Trapasso, F., Fedele, M., lppolito, P., Chiappetta, G., Botti, G., Fusco, A., and Persico, M. G. 1995. Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (P1GF) associated with malignancy in human thyroid tumors and cell lines. Oncogene 11:1569–1579.
Viglietto, G., Romano, A., Maglione, D., Rambaldi, M., Paoletti, I., Lago, C. T., Califano, D., Monaco, C., Mineo, A., Santelli, G., Manzo, G., Botti, G., Chiappetta, G., and Persico, M. G. 1996. Neovascularization in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta growth factor. Oncogene 13:577–587.
Viglietto, G., Romano, A., Manzo, G., Chiappetta, G., Paoletti, I., Califano, D., Galati, M. G., Mauriello, V., Bruni, P., Lago, C. T., Fusco, A., and Persico, M. G. 1997. Upregulation of the angiogenic factors P1GF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization. Oncogene 15:2687–2698.
Vuorela, P., Hatva, E., Lymboussaki, A., Kaipainen, A., Joukov, V., Persico, M. G., Alitalo, K., and Halmesmäki, E. 1997. Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol. Reprod. 56:489–494.
Vuorela-Vepsäläinen, P., Alfthan, H., Orpana, A., Alitalo, K., Stenman, U.-H., and Halmesmäki, E. 1999. Vascular endothelial growth factor is bound in amniotic fluid and maternal serum. Hum. Reprod. 14:1346–1351.
Wise, L. M., Veikkola, T., Mercer, A. A., Savory, L. J., Fleming, S. B., Caesar, C., Vitali, A., Makinen, Y., Alitalo, K., and Stacker, S. A. 1999. Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. Proc. Natl. Acad. Sci. USA 96:3071–3076.
Yonekura, H., Sakurai, S., Liu, X., Migita, H., Wang, H., Yamagishi, S., Nomura, M., Abedin, Md. J., Unoki, H., Yamamoto, Y., and Yamamoto, H. 1999. Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. J. Biol. Chem. 274:35172–35178.
Ziche, M., Maglione, D., Ribatti, D., Morbidelli, L., Lago, C. T., Battisti, M., Paoletti, I., Barra, A., Tucci, M., Parise, G., Vincenti, V., Granger, H. J., Viglietto, G., and Persico, M. G. 1997. Placenta growth factor-1 is chemotactic, mitogenic and angiogenic. Lab. Invest. 76:517–531.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Persico, M.G. (2001). Placenta Growth Factor. In: Augustin, H.G., Rogers, P.A.W., Iruela-Arispe, M.L., Smith, S.K. (eds) Vascular Morphogenesis in the Female Reproductive System. Cardiovascular Molecular Morphogenesis. Birkhäuser, Boston, MA. https://doi.org/10.1007/978-1-4612-0213-4_16
Download citation
DOI: https://doi.org/10.1007/978-1-4612-0213-4_16
Publisher Name: Birkhäuser, Boston, MA
Print ISBN: 978-1-4612-6665-5
Online ISBN: 978-1-4612-0213-4
eBook Packages: Springer Book Archive